Document:

Exhibit 10.1

 

RESTATED AND AMENDED EMPLOYMENT AGREEMENT

 

THIS RESTATED AND
AMENDED EMPLOYMENT AGREEMENT (“Agreement”) is made and shall be effective as of the 5th day of
June, 2019 (the “Effective Date”), by and between CAPRICOR THERAPEUTICS, INC.
(“CAPR”) and CAPRICOR, INC., (“Capricor”) whose offices are located at 8840
Wilshire Blvd., 2nd Floor, Beverly Hills, California 90211 (collectively, the “Company”), and LINDA
MARBAN, Ph.D., whose address is [***] (“Executive”).

 

RECITALS

 

A.        Executive
has been employed by the Company as its Chief Executive Officer pursuant to an Employment Agreement dated September 1, 2010 (“the
Original Employment Agreement”); and

 

B.         The
Company desires to amend and restate the terms of Executive’s employment and assure itself of the services of Executive
by continuing the employment of Executive under the terms set forth in this Agreement;

 

NOW, THEREFORE,
in consideration of the mutual covenants, promises, and agreements set forth herein and for good and valuable consideration, the
receipt and sufficiency of which are hereby acknowledged, the parties hereby mutually agree as follows:

 

1.           EMPLOYMENT.
As of the Effective Date of this Agreement, the Original Employment Agreement shall be restated, amended and superseded by this
Agreement. The Company hereby agrees to continue the employment of Executive, and Executive hereby agrees to accept the continuation
of her employment with the Company, upon the terms and conditions herein set forth.

 

2.            DUTIES
AND POWERS OF EXECUTIVE

 

2.1        Duties of Executive.
Executive shall serve as the Company’s Chief Executive Officer reporting directly to the Company’s Board of Directors.
In that capacity, Executive shall do and perform all services, acts or things necessary or advisable to manage the Company’s
business, including, without limitation, those duties set forth on Exhibit A, attached hereto (collectively, the “Services”).
Except as otherwise specifically set forth in this Agreement, during the duration of her employment, and except for periods of
illness, vacation, or reasonable leaves of absence, Executive shall devote her full time and attention to the business and affairs
of the Company, as such business and affairs now exist and as they hereafter may be changed or added to, under and pursuant to
the general direction of the Company’s Board of Directors (the “Board”).

 

    	 	 1	 

     

    

 

2.2        Place
of Performance.  Executive shall be expected to perform her Services primarily from the Company’s offices located
in Beverly Hills, California except for those occasions when Executive may elect to work remotely for short periods of time, not
to extend beyond ten (10) consecutive business days in duration unless otherwise agreed by the Company.

 

2.3        Other
Activities. Executive shall not provide any work or services for any other person or organization without the prior written
consent of the Board, which consent may be withheld in the Board’s sole and absolute discretion. Additionally, nothing contained
herein shall prohibit Executive from making passive personal investments in private or publicly traded companies so long as Executive’s
investment does not constitute an equity position greater than five percent (5%) of such company’s outstanding securities.

 

2.4        Company
Policies. By execution of this Agreement, Executive is agreeing to comply with all Company policies, procedures and standards
of conduct that are currently in effect or that may be established or modified by the Company from time to time.

 

3.           COMPENSATION

 

3.1        Base
Salary. In consideration of the Services to be provided by Executive during her employment hereunder, Executive shall receive
a base salary of one hundred fifty thousand dollars ($150,000) per annum (the “Base Salary”), which sum shall
be payable in semi-monthly installments consistent with Company pay practices.

 

3.2        Grant
of Stock Options. As further consideration for the Services to be provided by Executive hereunder, Executive shall be considered
for grants of stock options under CAPR’s 2012 Restated Equity Incentive Plan (the “Stock Plan”) to purchase
additional shares of Common Stock of CAPR (the “Option Shares”) at the discretion of the Company’s Board.
Option Shares shall be subject to the provisions of the Stock Plan and the applicable Stock Option Agreement to be executed by
CAPR and Executive.

  

3.3        Bonuses and Additional Compensation.
Along with other Executives of the Company, Executive shall be considered for Base Salary increases, bonuses or additional stock
options, the granting of which shall be determined in the sole discretion of the Company’s Compensation Committee and Board
of Directors, taking into consideration Executive’s performance and the performance of the Company as a whole. 

 

3.4        Deduction of
Taxes. The Company shall have the right to deduct or withhold from the compensation due to Executive hereunder any and
all sums required for Federal Income and Social Security taxes and all other federal, state or local taxes now applicable or that
may be enacted and become applicable in the future.         

   

    	 	 2	 

     

    

 

4.           OTHER
BENEFITS

 

4.1         Insurance.
So long as Executive remains employed by the Company, Executive shall be entitled to participate in the medical, dental and vision
insurance plans which are from time to time made available to other executives of the Company in accordance with the Company’s
policies then in effect. The right to receive such insurance benefits shall vest if and only if any of the foregoing types of insurance
plans are adopted and maintained by the Company. In addition, the sum of one thousand dollars ($1,000) shall be deposited into
a flexible spending account each year earmarked for Executive’s benefit to be used only for qualified medical expenses. If
Executive’s employment is terminated for whatever reason before such sum is expended by her, any remaining balance will be
cancelled upon termination of employment.

 

4.2          Paid Time Off
and Sick Pay.

 

(a)      Paid
Time Off. Executive shall be entitled to a maximum of twenty (20) working days’ off during each one-year period
of this Agreement without loss of compensation, to be taken at a time or times mutually agreed upon by the Company and Executive.
Paid time off days may be taken only at such times as are mutually convenient for the Company and Executive. Executive acknowledges
that all matters regarding paid time off will be subject to the Company’s written policy with respect thereto, a copy of
which has been provided to Executive.

 

 (b)     Sick
Days. Executive shall be entitled to take a maximum of six (6) sick days per calendar year without loss of compensation.
Executive acknowledges that all matters regarding sick leave will be subject to the Company’s written policy with respect
thereto. The Company reserves the right from time to time to alter, modify or eliminate benefits offered to its executives under
any of the Company’s policies or plans.

 

4.3        Business Expenses.
The Company shall reimburse Executive monthly for all reasonable business expenses incurred by Executive in performing the Services
hereunder, including, without limitation: (a) expenses incurred for business travel; (b) meals, lodging, and ground transportation
expenses incurred during business travel; (c) pre-approved promotional expenses; (d) long distance telephone charges; and (e) any
other expenses which the Company determines is necessary in connection with the performance of Executive’s Services hereunder.
Executive shall furnish to the Company adequate records, receipts and other documentary evidence required by federal and state
statutes and regulations issued by the appropriate taxing authorities for the substantiation of that expenditure as an income tax
deduction. All travel arrangements shall be in accordance with the Company’s Travel Policy.

 

4.4         Sarbanes-Oxley
Act of 2002. Notwithstanding anything herein to the contrary, if the Company determines, in its good faith judgment, that
any provision of this Agreement is likely to be interpreted as a personal loan prohibited by the Sarbanes-Oxley Act of 2002 and
the rules and regulations promulgated thereunder (the “Act”), then such provision shall be modified as necessary
or appropriate so as to not violate the Act and if this cannot be accomplished, then the Company shall use its reasonable efforts
to provide Executive with similar, but lawful, substitute benefits at a cost to the Company not to significantly exceed the amount
the Company would have otherwise paid to provide such benefit(s) to Executive.

 

    	 	 3	 

     

    

 

4.5        Modification
of Benefits. The Company reserves the right from time to time to alter, modify or eliminate benefits offered to
it Executives under any of the Company’s policies or plans.

 

5.           OBLIGATIONS
OF EXECUTIVE

 

5.1        Confidential
and Proprietary Information. Executive acknowledges and agrees that she has been given, and during the continuance of this
Agreement and in the course of discharging her duties hereunder, she will have access to and become acquainted with, information
and know-how concerning the operation, products and processes of the Company which are confidential and/or proprietary to the Company
(and/or its licensors and affiliates). As a condition of Executive’s employment, Executive acknowledges that she has executed
an At-Will Employment, Confidential Information, and Invention Assignment Agreement (the “Proprietary Rights Agreement”)
which, among other things, sets forth Executive’s obligations with respect to the Company’s confidential and proprietary
information. An executed copy of the Proprietary Rights Agreement shall be attached hereto as Exhibit B and incorporated
herein by reference.

 

5.2        Non-Competition
and Non-Solicitation by Executive. Executive acknowledges and agrees that her duty of loyalty to the Company is of paramount
importance. As a condition of Executive’s employment, Executive acknowledges and agrees to abide by the provisions regarding
non-competition and non-solicitation set forth in the Proprietary Rights Agreement attached hereto as Exhibit B.

 

5.3        Equitable
Remedies. In the event of a breach or threatened breach of the provisions of Section 5 of this Agreement, including its
subsections, the Company shall be entitled to an injunction enjoining Executive from such breach, but nothing herein shall be construed
as prohibiting the Company from pursuing in addition any other remedies available for such breach or threatened breach.

 

6.           COMPLIANCE
AND REPRESENTATIONS; ETHICAL CONDUCT

 

6.1        Ethical
Conduct. It is the policy of Capricor to conduct its business at all times in accordance with the highest standards
of corporate, business and medical ethics. Executive agrees to comply with those standards as more particularly set forth in the
Company’s Code of Conduct and Ethics in all matters relating to the Services and all other performance under or pursuant
to this Agreement. 

 

    	 	 4	 

     

    

 

6.2        Compliance
with Laws. In the performance of the Services hereunder, Executive will comply with all applicable laws, rules and regulations
of any government or governmental body or board having jurisdiction and all professional standards and guidelines or any code of
conduct which may be applicable to persons involved in the conduct of clinical trials.

 

6.3        No
Improper Payments. Executive agrees that she will not, either on her own behalf or on behalf of the Company, make any improper
payment or make any donation, or give anything of value, either directly or indirectly, to an official of any government for the
purpose of improperly influencing an act or decision of the official in his or her official capacity or inducing the official to
use his or her influence to assist Executive or the Company in obtaining or maintaining business or for any other improper purpose
prohibited by applicable law or the public policies of the U.S. or any country in which the Company’s business is conducted.

 

6.4        
No Political Payments. Executive shall not, in the name, on behalf or for the benefit of the Company or any of its
affiliates or in respect to any clinical trial which it is conducting, offer, pay, give, promise to pay or give, or authorize the
payment or gift of money or anything of value to any official, political party (or employee of a customer) or to any other person
at the request, suggestion or direction of any official, political party (or employee of a customer) or when all or a portion of
such money or thing of value will be offered, given or promised, directly or indirectly, to any such person for the purpose of
improperly obtaining or retaining business or favorable governmental action.

 

6.5        No Debarment.
Executive represents that as of the time of the signing of this Agreement, she has not been debarred in the conduct of clinical
trials and she will not knowingly use the services of any debarred person in connection with any work on any clinical trial conducted
by the Company. If, at any time after execution of this Agreement and continuing for a period of one (1) year after the termination
hereof, Executive becomes aware that she or any person utilized for the conduct of any of the Company’s clinical trials is
debarred, or is knowingly in the process of being debarred, Executive shall so notify the Company in writing immediately.

 

7.           TERMINATION OF EMPLOYMENT

 

7.1        At-Will
Employment. The employment of Executive shall continue and remain in effect until the termination hereof by either party.
The employment of Executive is “At-Will” and may be terminated at the will of either the Company or Executive, with
or without cause or notice.

 

7.2        Payments
Due Upon Termination. Upon termination of Executive’s employment for any reason, the Company shall pay to Executive
on such date required by applicable law, a lump sum amount in cash equal to Executive’s Base Salary and other payments due
through the date of termination to the extent not theretofore paid (“Accrued Amounts”).

 

    	 	 5	 

     

    

 

7.3        Severance Benefits.
 If Executive’s employment terminates due to an Involuntary Termination (as defined below), Executive will be eligible
to receive the additional compensation described in Subsection (a) below. This obligation to pay Severance Benefits shall be deemed
irrevocable and cannot be amended or revised unless Severance Benefits exceed what is stipulated in this Agreement or unless otherwise
agreed by the parties in writing.         

 

(a)       Involuntary
Termination. If at any time the Company, or any successor thereto, terminates Executive’s employment without Cause
(as defined below and other than as a result of Executive’s death or disability), or if Executive resigns for Good Reason
(as defined below), (such termination collectively described herein as an “Involuntary Termination”), Executive
will be entitled to receive the following severance benefits:

 

(i)      Executive will
be entitled to receive severance pay in the form of a lump sum payment representing six months’ (“Severance Amount”)
worth of Executive’s base salary then in effect (ignoring any decrease that forms the basis of Executive’s resignation
for Good Reason, if applicable). The payment of the Severance Amount shall be conditioned on Executive’s execution of a Severance
Agreement and General Release of all Claims provided by the Company, and the date upon which such payment will be made will be
determined pursuant to the terms set forth in the Severance Agreement.

 

(b)      Definitions.

 

(i)        “Cause”
means the occurrence of any of the following events, conditions or actions: (1) Executive’s conviction of any felony or any
crime involving fraud, dishonesty or moral turpitude; (2) Executive’s participation, whether by affirmative act or omission,
in any material fraud, material act of dishonesty or other material act of misconduct against the Company; (3) Executive’s
willful or habitual neglect of her duties, provided Executive has been given written notice of such neglect and, if curable, a
reasonable opportunity to cure, not to exceed ten (10) days; (4) Executive’s material violation of any fiduciary duty or
duty of loyalty owed to the Company; (5) Executive’s unauthorized use or disclosure of any confidential information or trade
secrets of the Company; (6) Executive’s breach of any material term of any material contract between Executive and the Company
which has a material adverse effect on the Company; (7) any misconduct by Executive which may have a materially adverse effect
upon the Company’s business or reputation; (8) the debarment of Executive or the institution against Executive or debarment
or disqualification proceedings; (9) Executive’s knowing violation of any material Company policy which has a material adverse
effect on the Company; or (10) Executive’s knowing violation of any state or federal law or regulation in connection with
the performance of her job responsibilities which has a material adverse effect on the Company.

 

    	 	 6	 

     

    

 

(ii)        “Good Reason”
means Executive’s resignation from employment with the Company (or successor to the company, if applicable) due to any of
the following actions taken by the Company (or successor to the Company, if applicable) without Executive’s prior written
consent thereto:

  

(1)      a reduction in Executive’s
base salary;

 

(2)      a material reduction
in Executive’s authority, title, duties or responsibilities excluding for this purpose an isolated, insubstantial and inadvertent
action not taken in bad faith and which is remedied by the Company promptly after receipt of notice thereof given by Executive;

 

(3)      a relocation
of Executive’s principal place of employment, whether a home office based personal residence or Company office, to a place
that increases Executive’s one-way commute by more than 25 miles as compared to Executive’s then-current principal
place of employment immediately prior to such relocation; and

 

(4)      the occurrence of any
illegal, unethical or inappropriate conduct by the Company in the conduct of its business.

 

(5)      Notwithstanding the foregoing,
in order to resign for Good Reason, Executive must (x) provide written notice to Company within twenty (20) days after the first
occurrence of the event giving rise to Good Reason setting forth the basis for Executive’s resignation; (y) allow the Company
at least ten (10) days from receipt of such written notice to cure such event, and (z) if such event is not reasonably cured within
such period, Executive’s resignation from all positions Executive holds with the Company shall be effective no later than
ten (10) days after the expiration of the cure period.

  

(iii)       “Disability”
means the physical or mental inability to perform substantially all of Executive’s duties for a continuous period of ninety
(90) days or more or such longer period mandated by applicable disability laws.

 

8.           GENERAL PROVISIONS

 

8.1        Notices.
Any notices to be given by either party to the other may be effected either by personal delivery in writing, by facsimile or electronic
transmission or by mail, registered or certified, postage prepaid. Mailed notices shall be addressed to the parties at the addresses
appearing in the introductory paragraph of this Agreement or such other address on file for Executive in Executive’s personnel
records, but each party may change its address by written notice in accordance with this section. Notices personally delivered
or sent by facsimile transmission shall be deemed communicated as of the date of actual receipt; mailed notices shall be deemed
communicated two (2) days after the date on which they are mailed.

 

    	 	 7	 

     

    

 

8.2        Entire
Agreement. This Agreement supersedes any and all other agreements, either oral or in writing, between the parties with
respect to the employment of Executive by the Company, excluding any Nondisclosure Agreement previously signed by Executive, the
Proprietary Rights Agreement, the written policies adopted by the Company from time to time, and a Dispute Resolution and Mutually
Binding Arbitration Agreement to be executed by the parties contemporaneous herewith, and contains all of the covenants and agreements
between the parties with respect to that employment in any manner whatsoever. Each party acknowledges that no representations,
inducements, promises, or agreements, orally or otherwise, other than those set forth herein, have been made by any party, or anyone
acting on behalf of any party, and that no other agreement, statement, or promise between the parties not contained in this Agreement
shall be valid or binding on the parties. Any modification of this Agreement will be effective only if it is in writing signed
by the party to be charged.

 

8.3       Severability.
 If any one or more provisions in this Agreement is held by a court of competent jurisdiction to be invalid, void, or unenforceable,
such provision shall be judicially modified accordingly to make such provision enforceable and if not possible to reasonably do
so, such provision shall be deemed excluded from this Agreement. In such case, the balance of this Agreement shall be interpreted
as if such provision were so excluded and shall be enforceable in accordance with its terms.

 

8.4        Waiver.
The failure of either party to insist on strict compliance with any of the terms, covenants, or conditions of this Agreement by
the other party shall not be deemed a waiver of that term, covenant, or condition, nor shall any waiver or relinquishment of any
right or power at any one time or times be deemed a waiver or relinquishment of that right or power for all or any other times.

 

8.5        Governing
Law. This Agreement and each of its provisions shall be governed by and construed in accordance with the laws of the State
of California (without regard to its conflict of law principles), except that the laws of the State of Delaware shall govern all
matters as to the Stock Plan and Stock Option Agreement.

 

8.6        Agreement
Binding. This Agreement shall inure to the benefit of and be binding upon the Company and its affiliates, successors and
assigns. The Company will require any successor (whether direct or indirect, by purchase, merger, consolidation or otherwise) to
all or substantially all of the business and/or assets of the Company to assume expressly and agree to perform this Agreement in
the same manner and to the same extent that the Company would be required to perform it as if no such succession had taken place.

 

8.7        Survival.
Notwithstanding any provision of this Agreement to the contrary, the provisions of Sections 5, 6, 7.2, 7.3 and 8 (and each of their
subsections) shall survive the expiration or termination of this Agreement as necessary to give full effect to all of the provisions
contained herein.

 

8.8        Headings
and Captions. Section headings and captions used in this Agreement are for reference only and shall not affect the construction
of this Agreement.

 

    	 	 8	 

     

    

 

Signature Page Follows

 

IN WITNESS WHEREOF, the
parties have caused this Agreement to be executed as of the Effective Date. 

 

	Capricor Therapeutics, Inc.	 	Executive:
	 	 	 
	By:	/s/ Karen Krasney	 	By:	/s/ Linda Marban
	 	 	 	 	 
	Name:	Karen Krasney	 	Name:	Linda Marbán Ph.D.
	 	 	 	 	 
	Title:	EVP, General Counsel	 	 	 

  

	Capricor, Inc.	 
	 	 
	By:	/s/ Karen Krasney	 
	 	 	 
	Name:	Karen Krasney	 
	 	 	 
	Title:	EVP, General Counsel	 

 

    	 	 9	 

     

    

  

EXHIBIT A

 

DESCRIPTION OF THE SERVICES

 

The Services to be performed by Executive shall
include, without limitation, the following:

 

(a)         managing,
overseeing, and directing the Company’s operations;

 

(b)         being
primarily responsible for implementing the strategic goals and objectives of the Company;

 

(c)         giving
direction and leadership to the achievement of the Company’s philosophy, mission, annual goals and objectives;

 

(d)         supporting
operations and the administration of the Company’s Board of Directors by advising and informing Board members and interfacing
between Board members and staff;

 

(e)         overseeing
the design, marketing, promotion, and quality of the Company’s products and services;

 

(f)          together
with any Chief Financial Officer, any Vice President of Finance, or other appropriate officers, recommending an annual budget for
Board approval and prudently managing the Company’s resources with those budget guidelines according to current laws and
regulations;

 

(g)         effectively
managing the Company’s human resources according to authorized personnel policies and procedures that fully conform to current
laws and regulations;

 

(h)         ensuring
that the Company and its programs, products, and services are consistently presented truthfully and accurately to stockholders
and the public;

 

(i)          overseeing
investor relations, and fundraising planning and implementation, including identifying resource requirements, researching funding
sources, establishing strategies to approach investors, submitting proposals, and managing investor records and documentation;

 

(j)           assisting
in the selection and evaluation of Board members;

 

(k)          being
available as a contact for appropriate investors;

 

(l)           providing strategic counsel to the Board of Directors regarding the Company’s growth prospects;

 

    	 	 10	 

     

    

  

(m)        ensuring that all financial and non-financial reporting requirements are met on a timely and regular basis; and

 

(n)         performing
such other managerial and operational functions within or outside the scope of the above-referenced services as may be requested
from time to time by the Board of Directors.

 

EXHIBIT B

 

PROPRIETARY RIGHTS AGREEMENT

  

    	 	 11Exhibit 10.2

 

EMPLOYMENT
AGREEMENT

 

THIS EMPLOYMENT AGREEMENT
(“Agreement”) is made and shall be effective as of the 14th day of May, 2019 (the “Effective Date”),
by and between CAPRICOR THERAPEUTICS, INC. (“CAPR”) and CAPRICOR, INC., (“Capricor”)
whose offices are located at 8840 Wilshire Blvd., 2nd Floor, Beverly Hills, California 90211 (collectively, the “Company”),
and ANTHONY J. BERGMANN, whose address is [***] (“Executive”).

 

RECITALS

 

A.        Executive
has been employed by the Company since May, 2011 and is now serving as its Chief Financial Officer pursuant to an oral employment
agreement; and

 

B.        The Company desires
to memorialize the terms of Executive’s employment and assure itself of the services of Executive by continuing the employment
of Executive under the terms set forth in this Agreement;

 

NOW, THEREFORE,
in consideration of the mutual covenants, promises, and agreements set forth herein and for good and valuable consideration, the
receipt and sufficiency of which are hereby acknowledged, the parties hereby mutually agree as follows:

 

1.           EMPLOYMENT.
The Company hereby agrees to continue the employment of Executive, and Executive hereby agrees to accept the continuation of employment
with the Company, upon the terms and conditions herein set forth.

 

2.            DUTIES
AND POWERS OF EXECUTIVE

 

2.1        Duties of Executive.
Executive shall serve as the Company’s Chief Financial Officer reporting directly to the Chief Executive Officer (“CEO”).
In that capacity, Executive will have primary responsibility for planning, implementing, managing and controlling all financial-related
activities of the Company, including responsibility and oversight for accounting, finance, forecasting, strategic planning, deal
analysis, investor relationships and private and institutional financing. Employee will also be expected to represent the Company,
along with the CEO, at meetings with investment bankers and investors (collectively, the “Services”). Except
as otherwise specifically set forth in this Agreement, during the duration of his employment, and except for periods of illness,
vacation, or reasonable leaves of absence, Executive shall devote his full time and attention to the business and affairs of the
Company, as such business and affairs now exist and as they hereafter may be changed or added to, under and pursuant to the general
direction of the Company’s Board of Directors (the “Board”).

 

    	 	 1	 

     

    

 

2.2        Place
of Performance.  Executive shall be expected to perform his Services primarily from the Company’s offices located
in Beverly Hills, California except for those occasions when Executive may elect to work remotely for short periods of time, not
to extend beyond ten (10) consecutive business days in duration unless otherwise agreed by the Company.

 

2.3        Other
Activities. Executive shall not provide any work or services for any other person or organization without the prior written
consent of the CEO, which consent may be withheld in the CEO’s sole and absolute discretion. Additionally, nothing contained
herein shall prohibit Executive from making passive personal investments in private or publicly traded companies so long as Executive’s
investment does not constitute an equity position greater than five percent (5%) of such company’s outstanding securities.

 

2.4        Company
Policies. By execution of this Agreement, Executive is agreeing to comply with all Company policies, procedures and standards
of conduct that are currently in effect or that may be established or modified by the Company from time to time.

 

3.           COMPENSATION

 

3.1        Base
Salary. In consideration of the Services to be provided by Executive during his employment hereunder, Executive shall receive
a base salary of two hundred thousand dollars ($200,000) per annum (the “Base Salary”), which sum shall be payable
in semi-monthly installments consistent with Company pay practices.

 

3.2        Grant
of Stock Options. As further consideration for the Services to be provided by Executive hereunder, Executive shall be considered
for grants of stock options under CAPR’s 2012 Restated Equity Incentive Plan (the “Stock Plan”) to purchase
additional shares of Common Stock of CAPR (the “Option Shares”) at the discretion of the Company’s Board.
Option Shares shall be subject to the provisions of the Stock Plan and the applicable Stock Option Agreement to be executed by
CAPR and Executive.

 

3.3       
Bonuses and Additional Compensation. Along with other Executives of the Company, Executive shall be considered for
Base Salary increases, bonuses or additional stock options, the granting of which shall be determined in the sole discretion of
the Company’s Compensation Committee and Board of Directors, taking into consideration Executive’s performance and
the performance of the Company as a whole. 

 

3.4        Deduction of
Taxes. The Company shall have the right to deduct or withhold from the compensation due to Executive hereunder any and
all sums required for Federal Income and Social Security taxes and all other federal, state or local taxes now applicable or that
may be enacted and become applicable in the future.

 

    	 	 2	 

     

    

 

4.           OTHER
BENEFITS

 

4.1         Insurance.
So long as Executive remains employed by the Company, Executive shall be entitled to participate in the medical, dental and vision
insurance plans which are from time to time made available to other executives of the Company in accordance with the Company’s
policies then in effect. The right to receive such insurance benefits shall vest if and only if any of the foregoing types of insurance
plans are adopted and maintained by the Company. In addition, the sum of one thousand dollars ($1,000) shall be deposited into
a flexible spending account each year earmarked for Executive’s benefit to be used only for qualified medical expenses. If
Executive’s employment is terminated for whatever reason before such sum is expended by him, any remaining balance will be
cancelled upon termination of employment.

 

4.2          Paid Time Off
and Sick Pay.

 

(a)     Paid
Time Off. Executive shall be entitled to a maximum of twenty (20) working days’ off during each one-year period
of this Agreement without loss of compensation, to be taken at a time or times mutually agreed upon by the Company and Executive.
Paid time off days may be taken only at such times as are mutually convenient for the Company and Executive. Executive acknowledges
that all matters regarding paid time off will be subject to the Company’s written policy with respect thereto, a copy of
which has been provided to Executive.

 

 (b)     Sick
Days. Executive shall be entitled to take a maximum of six (6) sick days per calendar year without loss of compensation.
Executive acknowledges that all matters regarding sick leave will be subject to the Company’s written policy with respect
thereto. The Company reserves the right from time to time to alter, modify or eliminate benefits offered to its executives under
any of the Company’s policies or plans.

 

4.3        Business Expenses.
The Company shall reimburse Executive monthly for all reasonable business expenses incurred by Executive in performing the Services
hereunder, including, without limitation: (a) expenses incurred for business travel; (b) meals, lodging, and ground transportation
expenses incurred during business travel; (c) pre-approved promotional expenses; (d) long distance telephone charges; and (e) any
other expenses which the Company determines is necessary in connection with the performance of Executive’s Services hereunder.
Executive shall furnish to the Company adequate records, receipts and other documentary evidence required by federal and state
statutes and regulations issued by the appropriate taxing authorities for the substantiation of that expenditure as an income tax
deduction. All travel arrangements shall be in accordance with the Company’s Travel Policy.

 

4.4         Sarbanes-Oxley
Act of 2002. Notwithstanding anything herein to the contrary, if the Company determines, in its good faith judgment, that
any provision of this Agreement is likely to be interpreted as a personal loan prohibited by the Sarbanes-Oxley Act of 2002 and
the rules and regulations promulgated thereunder (the “Act”), then such provision shall be modified as necessary
or appropriate so as to not violate the Act and if this cannot be accomplished, then the Company shall use its reasonable efforts
to provide Executive with similar, but lawful, substitute benefits at a cost to the Company not to significantly exceed the amount
the Company would have otherwise paid to provide such benefit(s) to Executive.

  

    	 	 3	 

     

    

 

4.5        Modification
of Benefits. The Company reserves the right from time to time to alter, modify or eliminate benefits offered to
it Executives under any of the Company’s policies or plans.

 

5.           OBLIGATIONS
OF EXECUTIVE

 

5.1        Confidential
and Proprietary Information. Executive acknowledges and agrees that he has been given, and during the continuance of this
Agreement and in the course of discharging his duties hereunder, he will have access to and become acquainted with, information
and know-how concerning the operation, products and processes of the Company which are confidential and/or proprietary to the Company
(and/or its licensors and affiliates). As a condition of Executive’s employment, Executive acknowledges that he has executed
an At-Will Employment, Confidential Information, and Invention Assignment Agreement (the “Proprietary Rights Agreement”)
which, among other things, sets forth Executive’s obligations with respect to the Company’s confidential and proprietary
information. An executed copy of the Proprietary Rights Agreement shall be attached hereto as Exhibit A and incorporated
herein by reference.

 

5.2        Non-Competition
and Non-Solicitation by Executive. Executive acknowledges and agrees that his duty of loyalty to the Company is of paramount
importance. As a condition of Executive’s employment, Executive acknowledges and agrees to abide by the provisions regarding
non-competition and non-solicitation set forth in the Proprietary Rights Agreement attached hereto as Exhibit A.

 

5.3        Equitable
Remedies. In the event of a breach or threatened breach of the provisions of Section 5 of this Agreement, including its
subsections, the Company shall be entitled to an injunction enjoining Executive from such breach, but nothing herein shall be construed
as prohibiting the Company from pursuing in addition any other remedies available for such breach or threatened breach.

 

6.           COMPLIANCE
AND REPRESENTATIONS; ETHICAL CONDUCT

 

6.1        Ethical
Conduct. It is the policy of Capricor to conduct its business at all times in accordance with the highest standards
of corporate, business and medical ethics. Executive agrees to comply with those standards as more particularly set forth in the
Company’s Code of Conduct and Ethics in all matters relating to the Services and all other performance under or pursuant
to this Agreement. 

 

6.2        Compliance
with Laws. In the performance of the Services hereunder, Executive will comply with all applicable laws, rules and regulations
of any government or governmental body or board having jurisdiction and all professional standards and guidelines or any code of
conduct which may be applicable to persons involved in the conduct of clinical trials.

 

    	 	 4	 

     

    

 

6.3        No
Improper Payments. Executive agrees that he will not, either on his own behalf or on behalf of the Company, make any improper
payment or make any donation, or give anything of value, either directly or indirectly, to an official of any government for the
purpose of improperly influencing an act or decision of the official in his or her official capacity or inducing the official to
use his or her influence to assist Executive or the Company in obtaining or maintaining business or for any other improper purpose
prohibited by applicable law or the public policies of the U.S. or any country in which the Company’s business is conducted.

 

6.4        
No Political Payments. Executive shall not, in the name, on behalf or for the benefit of the Company or any of its
affiliates or in respect to any clinical trial which it is conducting, offer, pay, give, promise to pay or give, or authorize the
payment or gift of money or anything of value to any official, political party (or employee of a customer) or to any other person
at the request, suggestion or direction of any official, political party (or employee of a customer) or when all or a portion of
such money or thing of value will be offered, given or promised, directly or indirectly, to any such person for the purpose of
improperly obtaining or retaining business or favorable governmental action.

 

6.5        No Debarment.
Executive represents that as of the time of the signing of this Agreement, he has not been debarred in the conduct of clinical
trials and he will not knowingly use the services of any debarred person in connection with any work on any clinical trial conducted
by the Company. If, at any time after execution of this Agreement and continuing for a period of one (1) year after the termination
hereof, Executive becomes aware that he or any person utilized for the conduct of any of the Company’s clinical trials is
debarred, or is knowingly in the process of being debarred, Executive shall so notify the Company in writing immediately.

 

7.           TERMINATION OF EMPLOYMENT

 

7.1        At-Will
Employment. The employment of Executive shall continue and remain in effect until the termination hereof by either party.
The employment of Executive is “At-Will” and may be terminated at the will of either the Company or Executive, with
or without cause or notice.

 

7.2        Payments
Due Upon Termination. Upon termination of Executive’s employment for any reason, the Company shall pay to Executive
on such date required by applicable law, a lump sum amount in cash equal to Executive’s Base Salary and other payments due
through the date of termination to the extent not theretofore paid (“Accrued Amounts”).

 

7.3      
Severance Benefits.  If Executive’s employment terminates due to an Involuntary Termination (as defined below),
Executive will be eligible to receive the additional compensation described in Subsection (a) below. This obligation to pay Severance
Benefits shall be deemed irrevocable and cannot be amended or revised unless Severance Benefits exceed what is stipulated in this
Agreement or unless otherwise agreed by the parties in writing.

 

    	 	 5	 

     

    

 

(a)      Involuntary Termination.
If at any time the Company, or any successor thereto, terminates Executive’s employment without Cause (as defined below and
other than as a result of Executive’s death or disability), or if Executive resigns for Good Reason (as defined below), (such
termination collectively described herein as an “Involuntary Termination”), Executive will be entitled to receive
the following severance benefits:

 

(i)      
Executive will be entitled to receive severance pay in the form of a lump sum payment representing six months’ (“Severance
Amount”) worth of Executive’s base salary then in effect (ignoring any decrease
that forms the basis of Executive’s resignation for Good Reason, if applicable). The payment of the Severance Amount shall
be conditioned on Executive’s execution of a Severance Agreement and General Release of all Claims provided by the Company,
and the date upon which such payment will be made will be determined pursuant to the terms set forth in the Severance Agreement.

 

(b)      Definitions.

 

(i)       “Cause”
means the occurrence of any of the following events, conditions or actions: (1) Executive’s conviction of any felony or any
crime involving fraud, dishonesty or moral turpitude; (2) Executive’s participation, whether by affirmative act or omission,
in any material fraud, material act of dishonesty or other material act of misconduct against the Company; (3) Executive’s
willful or habitual neglect of his duties, provided Executive has been given written notice of such neglect and, if curable, a
reasonable opportunity to cure, not to exceed ten (10) days; (4) Executive’s material violation of any fiduciary duty or
duty of loyalty owed to the Company; (5) Executive’s unauthorized use or disclosure of any confidential information or trade
secrets of the Company; (6) Executive’s breach of any material term of any material contract between Executive and the Company
which has a material adverse effect on the Company; (7) any misconduct by Executive which may have a materially adverse effect
upon the Company’s business or reputation; (8) the debarment of Executive or the institution against Executive or debarment
or disqualification proceedings; (9) Executive’s knowing violation of any material Company policy which has a material adverse
effect on the Company; or (10) Executive’s knowing violation of any state or federal law or regulation in connection with
the performance of his job responsibilities which has a material adverse effect on the Company.

  

    	 	 6	 

     

    

 

(ii)        “Good Reason”
means Executive’s resignation from employment with the Company (or successor to the company, if applicable) due to any of
the following actions taken by the Company (or successor to the Company, if applicable) without Executive’s prior written
consent thereto:

 

(1)      a reduction in Executive’s
base salary;

 

(2)      a material reduction
in Executive’s authority, title, duties or responsibilities excluding for this purpose an isolated, insubstantial and inadvertent
action not taken in bad faith and which is remedied by the Company promptly after receipt of notice thereof given by Executive;

 

(3)      a relocation
of Executive’s principal place of employment, whether a home office based personal residence or Company office, to a place
that increases Executive’s one-way commute by more than 25 miles as compared to Executive’s then-current principal
place of employment immediately prior to such relocation;

 

(4)      the occurrence of any
illegal, unethical or inappropriate conduct by the Company in the conduct of its business; and.

 

(5)      Notwithstanding the foregoing,
in order to resign for Good Reason, Executive must (x) provide written notice to Company within twenty (20) days after the first
occurrence of the event giving rise to Good Reason setting forth the basis for Executive’s resignation; (y) allow the Company
at least ten (10) days from receipt of such written notice to cure such event, and (z) if such event is not reasonably cured within
such period, Executive’s resignation from all positions Executive holds with the Company shall be effective no later than
ten (10) days after the expiration of the cure period.

 

(iii)       “Disability”
means the physical or mental inability to perform substantially all of Executive’s duties for a continuous period of ninety
(90) days or more or such longer period mandated by applicable disability laws.

 

8.           GENERAL PROVISIONS

 

8.1        Notices.
Any notices to be given by either party to the other may be effected either by personal delivery in writing, by facsimile or electronic
transmission or by mail, registered or certified, postage prepaid. Mailed notices shall be addressed to the parties at the addresses
appearing in the introductory paragraph of this Agreement or such other address on file for Executive in Executive’s personnel
records, but each party may change its address by written notice in accordance with this section. Notices personally delivered
or sent by facsimile transmission shall be deemed communicated as of the date of actual receipt; mailed notices shall be deemed
communicated two (2) days after the date on which they are mailed.

 

8.2        Entire
Agreement. This Agreement supersedes any and all other agreements, either oral or in writing, between the parties with
respect to the employment of Executive by the Company, excluding any Nondisclosure Agreement previously signed by Executive, the
Proprietary Rights Agreement, the written policies adopted by the Company from time to time, and a Dispute Resolution and Mutually
Binding Arbitration Agreement to be executed by the parties contemporaneous herewith, and contains all of the covenants and agreements
between the parties with respect to that employment in any manner whatsoever. Each party acknowledges that no representations,
inducements, promises, or agreements, orally or otherwise, other than those set forth herein, have been made by any party, or anyone
acting on behalf of any party, and that no other agreement, statement, or promise between the parties not contained in this Agreement
shall be valid or binding on the parties. Any modification of this Agreement will be effective only if it is in writing signed
by the party to be charged.

 

    	 	 7	 

     

    

 

8.3       Severability.
 If any one or more provisions in this Agreement is held by a court of competent jurisdiction to be invalid, void, or unenforceable,
such provision shall be judicially modified accordingly to make such provision enforceable and if not possible to reasonably do
so, such provision shall be deemed excluded from this Agreement. In such case, the balance of this Agreement shall be interpreted
as if such provision were so excluded and shall be enforceable in accordance with its terms.

 

8.4        Waiver.
The failure of either party to insist on strict compliance with any of the terms, covenants, or conditions of this Agreement by
the other party shall not be deemed a waiver of that term, covenant, or condition, nor shall any waiver or relinquishment of any
right or power at any one time or times be deemed a waiver or relinquishment of that right or power for all or any other times.

 

8.5        Governing
Law. This Agreement and each of its provisions shall be governed by and construed in accordance with the laws of the State
of California (without regard to its conflict of law principles), except that the laws of the State of Delaware shall govern all
matters as to the Stock Plan and Stock Option Agreement.

 

8.6        Agreement
Binding. This Agreement shall inure to the benefit of and be binding upon the Company and its affiliates, successors and
assigns. The Company will require any successor (whether direct or indirect, by purchase, merger, consolidation or otherwise) to
all or substantially all of the business and/or assets of the Company to assume expressly and agree to perform this Agreement in
the same manner and to the same extent that the Company would be required to perform it as if no such succession had taken place.

 

8.7        Survival.
Notwithstanding any provision of this Agreement to the contrary, the provisions of Sections 5, 6, 7.2, 7.3 and 8 (and each of their
subsections) shall survive the expiration or termination of this Agreement as necessary to give full effect to all of the provisions
contained herein.

 

8.8        Headings
and Captions. Section headings and captions used in this Agreement are for reference only and shall not affect the construction
of this Agreement.

 

    	 	 8	 

     

    

  

Signature Page Follows

 

IN WITNESS WHEREOF, the
parties have caused this Agreement to be executed as of the Effective Date.

  

	Capricor Therapeutics, Inc.	 	Executive:
	 	 	 
	By:	/s/ Linda Marban	 	By:	/s/ Anthony Bergmann
	 	 	 	 	 
	Name:	Linda Marban	 	Name:	Anthony J. Bergmann
	 	 	 	 	 
	Title:	CEO	 	 	 

  

	Capricor, Inc.	 	 
	 	 	 
	By:	/s/ Linda Marban	 	 	 
	 	 	 	 	 
	Name:	Linda Marban	 	 	 
	 	 	 	 	 
	Title:	CEO	 	 	 

 

    	 	 9	 

     

    

  

EXHIBIT A

 

PROPRIETARY RIGHTS AGREEMENT

 

    	 	 10

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00298-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00298-of-00352.parquet"}]]